We are live on ! Find out more
TGX

THERAGENICS CORP
TGX

Delisted

TGX was delisted on the 29th of October, 2013.

0 hedge funds and large institutions have $0 invested in THERAGENICS CORP in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 410 (-41)

100% less capital invested

Capital invested by funds: $32.3M → $0 (-$32.3M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 41

Holders
Holders Change
-41
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
41
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
26
State Street
Massachusetts
-$66K -30,181 Closed
HM
27
Harvest Management
New York
-$65K -30,000 Closed
U
28
UBS
Switzerland
-$44K -20,364 Closed
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
-$39K -18,011 Closed
Morgan Stanley
30
Morgan Stanley
New York
-$38K -17,400 Closed
Citadel Advisors
31
Citadel Advisors
Florida
-$33K -15,221 Closed
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
-$22K -10,000 Closed
BA
33
BlackRock Advisors
Delaware
-$12K -5,558 Closed
FNYS
34
First New York Securities
New York
-$6K -3,200 Closed
NFA
35
Nationwide Fund Advisors
Ohio
-$7K -3,000 Closed
Bank of America
36
Bank of America
North Carolina
-$6K -2,720 Closed
AIG
37
American International Group
New York
-$4.36K -2,000 Closed
MAM
38
Meeder Asset Management
Ohio
-$4K -1,750 Closed
Wells Fargo
39
Wells Fargo
California
-$2K -1,000 Closed
TRCT
40
Tower Research Capital (TRC)
New York
-$2K -900 Closed

TGX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in THERAGENICS CORP (TGX) for Q4 2013, worth a combined $0 — down 100% from $32.3M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of TGX and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $6.73M sold.

  • 0 institutional investors held THERAGENICS CORP (TGX) as of Q4 2013, down from 41 in Q3 2013.
  • Funds reported $0 of THERAGENICS CORP stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new THERAGENICS CORP positions in Q4 2013 and 41 closed out, a net change of -41 holders.
  • The largest THERAGENICS CORP seller in Q4 2013 was Fidelity Investments, an estimated $6.73M sold.

Based on aggregated 13F filings for Q4 2013.